• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾南部单微生物菌血症住院成人对第三代头孢菌素不敏感的临床影响及危险因素:一项多中心研究

Clinical Impact and Risk Factors of Nonsusceptibility to Third-Generation Cephalosporins Among Hospitalized Adults with Monomicrobial Bacteremia in Southern Taiwan: A Multicenter Study.

作者信息

Lin Tsao-Chin, Hung Yuan-Pin, Lee Ching-Chi, Lin Wei-Tang, Huang Li-Chen, Dai Wei, Kuo Chi-Shuang, Ko Wen-Chien, Huang Yeou-Lih

机构信息

Department of Medical Laboratory and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan.

Medical Laboratory, Sinying Hospital, Ministry of Health and Welfare, Tainan, Taiwan.

出版信息

Infect Drug Resist. 2021 Feb 24;14:689-697. doi: 10.2147/IDR.S297978. eCollection 2021.

DOI:10.2147/IDR.S297978
PMID:33658807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7918563/
Abstract

BACKGROUND

Reducing the effectiveness of broad-spectrum cephalosporins against infections has been recognized. This study aimed to investigate risk factors and clinical significance of third-generation cephalosporin nonsusceptibility (3GC-NS) among the cases of monomicrobial bacteremia (mEB) at regional or district hospitals.

METHODS

The study was conducted at three hospitals in southern Taiwan between Jan. 2017 and Oct. 2019. Only the first episode of mEB from each adult (aged ≥20 years) was included. The primary outcome was in-hospital crude mortality.

RESULTS

Overall there were 499 episodes of adults with mEB included, and their mean age was 74.5 years. Female predominated, accounting for 53% of all patients. (62%) and (21%) were two major causative species. The overall mortality rate was 15% (73/499), and patients infected by 3GC-NS isolates (34%, 172/499) had a higher mortality rate than those by 3GC-susceptible isolates (66%, 327/499) (21% vs 11%, =0.005). By the multivariate analysis, 3GC-NS was the only independent prognostic determinant (adjusted odds ratio [AOR], 1.78; =0.04). Of note, male (AOR 2.02, =0.001), nosocomial-acquired bacteremia (AOR 2.77, <0.001), and usage of nasogastric tube (AOR 2.01, =0.002) were positively associated with 3GC-NS, but bacteremia (AOR 0.28, =0.01) and age (AOR 0.98, =0.04) negatively with 3GC-NS.

CONCLUSION

For adults with bacteremia, 3GC-NS signifies a significant prognostic impact. Efforts to rapid identification of such antimicrobial resistance profiles should be incorporated into antimicrobial stewardship programs to achieve favorable outcomes.

摘要

背景

广谱头孢菌素抗感染效力下降的情况已得到公认。本研究旨在调查地区或区级医院单微生物菌血症(mEB)病例中第三代头孢菌素不敏感(3GC-NS)的危险因素及临床意义。

方法

本研究于2017年1月至2019年10月在台湾南部的三家医院进行。仅纳入每位成年人(年龄≥20岁)的首次mEB发作。主要结局是院内粗死亡率。

结果

共纳入499例成人mEB发作病例,平均年龄为74.5岁。女性居多,占所有患者的53%。[具体细菌名称1](62%)和[具体细菌名称2](21%)是两个主要致病菌。总体死亡率为15%(73/499),感染3GC-NS菌株的患者(34%,172/499)的死亡率高于感染3GC敏感菌株的患者(66%,327/499)(21%对11%,P = 0.005)。多因素分析显示,3GC-NS是唯一的独立预后决定因素(校正比值比[AOR],1.78;P = 0.04)。值得注意的是,男性(AOR 2.02,P = 0.001)、医院获得性菌血症(AOR 2.77,P < 0.001)和使用鼻胃管(AOR 2.01,P = 0.002)与3GC-NS呈正相关,而[具体细菌名称1]菌血症(AOR 0.28,P = 0.01)和年龄(AOR 0.98,P = 0.04)与3GC-NS呈负相关。

结论

对于患有[具体细菌名称1]菌血症的成年人,3GC-NS具有显著的预后影响。应将快速鉴定此类抗菌药物耐药谱的工作纳入抗菌药物管理计划,以取得良好效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4881/7918563/a6083fd92abe/IDR-14-689-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4881/7918563/a6083fd92abe/IDR-14-689-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4881/7918563/a6083fd92abe/IDR-14-689-g0001.jpg

相似文献

1
Clinical Impact and Risk Factors of Nonsusceptibility to Third-Generation Cephalosporins Among Hospitalized Adults with Monomicrobial Bacteremia in Southern Taiwan: A Multicenter Study.台湾南部单微生物菌血症住院成人对第三代头孢菌素不敏感的临床影响及危险因素:一项多中心研究
Infect Drug Resist. 2021 Feb 24;14:689-697. doi: 10.2147/IDR.S297978. eCollection 2021.
2
Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.台湾一家医学中心社区获得性第三代头孢菌素耐药大肠埃希菌菌血症的流行率及危险因素。
BMC Infect Dis. 2019 Mar 12;19(1):245. doi: 10.1186/s12879-019-3880-z.
3
Risk factors and clinical impact of bacteremia due to carbapenem-nonsusceptible Enterobacteriaceae: A multicenter study in southern Taiwan.耐碳青霉烯类肠杆菌科细菌血症的危险因素和临床影响:台湾南部的一项多中心研究。
J Microbiol Immunol Infect. 2021 Dec;54(6):1122-1129. doi: 10.1016/j.jmii.2021.05.005. Epub 2021 Jun 25.
4
Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?在医院层面,肺炎克雷伯菌和大肠杆菌中阿莫西林-克拉维酸的使用与对第三代头孢菌素的耐药性之间是否存在关联?
Microb Drug Resist. 2018 Sep;24(7):987-994. doi: 10.1089/mdr.2017.0360. Epub 2018 Feb 28.
5
Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.八项撒哈拉以南非洲医院(MBIRA)血流感染肠杆菌科第三代头孢菌素耐药相关死亡率的前瞻性队列研究。
Lancet Infect Dis. 2023 Nov;23(11):1280-1290. doi: 10.1016/S1473-3099(23)00233-5. Epub 2023 Jul 13.
6
Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.脓毒症患者中第三代头孢菌素耐药肠杆菌科细菌血症的定植和抗生素使用的预测价值。
Clin Infect Dis. 2015 Jun 1;60(11):1622-30. doi: 10.1093/cid/civ121. Epub 2015 Feb 18.
7
Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.比较第三代头孢菌素和广谱β-内酰胺类药物作为成人社区获得性单一致病菌血症的经验性治疗的疗效:倾向评分匹配分析。
Int J Antimicrob Agents. 2017 May;49(5):617-623. doi: 10.1016/j.ijantimicag.2017.01.006. Epub 2017 Mar 14.
8
The Clinical Evaluation of Third-generation Cephalosporins As Definitive Therapy for Enterobacter spp. and Klebsiella aerogenes Bacteremia.三代头孢菌素作为肠杆菌属和产酸克雷伯菌菌血症的确定性治疗的临床评估。
Intern Med. 2023 Jul 1;62(13):1921-1929. doi: 10.2169/internalmedicine.0612-22. Epub 2022 Nov 16.
9
Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.一家二级医院社区获得性大肠杆菌和肺炎克雷伯菌血流感染的第三代头孢菌素耐药性
Korean J Intern Med. 2014 Jan;29(1):49-56. doi: 10.3904/kjim.2014.29.1.49. Epub 2014 Jan 2.
10
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.黎巴嫩发热性中性粒细胞减少成年癌症患者中引起菌血症的第三代头孢菌素耐药肠杆菌科细菌和多重耐药革兰氏阴性菌、作为主要危险因素的广谱抗生素使用以及与预后不良的相关性
Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015.

引用本文的文献

1
The Resistance Mechanisms and Clinical Impact of Resistance to the Third Generation Cephalosporins in Species of Complex in Taiwan.台湾地区复杂菌属中对第三代头孢菌素耐药的耐药机制及临床影响
Antibiotics (Basel). 2022 Aug 26;11(9):1153. doi: 10.3390/antibiotics11091153.

本文引用的文献

1
Biological activities of essential oil extracted from leaves of Atalantia sessiflora Guillauminin Vietnam.越南白胶木叶片精油的生物活性。
J Infect Dev Ctries. 2020 Sep 30;14(9):1054-1064. doi: 10.3855/jidc.12469.
2
The Hypotension Period after Initiation of Appropriate Antimicrobial Administration Is Crucial for Survival of Bacteremia Patients Initially Experiencing Severe Sepsis and Septic Shock.开始适当抗菌治疗后的低血压期对于最初经历严重脓毒症和感染性休克的菌血症患者的存活至关重要。
J Clin Med. 2020 Aug 12;9(8):2617. doi: 10.3390/jcm9082617.
3
Phytochemical Compositions and Biological Activities of Essential Oils from the Leaves, Rhizomes and Whole Plant of Škorničk.
斯科尔尼茨克(Škorničk)叶、根茎及全株精油的植物化学成分与生物活性
Antibiotics (Basel). 2020 Jun 18;9(6):334. doi: 10.3390/antibiotics9060334.
4
Biological Activities of Essential Oils from Leaves of (Oliv.) Guillaum and (Miq.) Swingle.(奥利弗)吉约姆和(米克)斯温格尔叶片挥发油的生物活性
Antibiotics (Basel). 2020 Apr 24;9(4):207. doi: 10.3390/antibiotics9040207.
5
Risk Factors of Initial Inappropriate Antibiotic Therapy and the Impacts on Outcomes of Neonates with Gram-Negative Bacteremia.新生儿革兰阴性菌血症初始不适当抗生素治疗的危险因素及其对预后的影响。
Antibiotics (Basel). 2020 Apr 23;9(4):203. doi: 10.3390/antibiotics9040203.
6
Enhancement of antimicrobial activity of pump inhibitors associating drugs.增强与质子泵抑制剂联合使用药物的抗菌活性。
J Infect Dev Ctries. 2019 Feb 28;13(2):162-164. doi: 10.3855/jidc.11102.
7
In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant .精油对革兰氏阳性和革兰氏阴性临床分离株的体外活性,包括耐碳青霉烯类菌株
Open Forum Infect Dis. 2019 Dec 4;6(12):ofz502. doi: 10.1093/ofid/ofz502. eCollection 2019 Dec.
8
Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia.早期经验性应用适当抗菌药物对社区获得性菌血症成人的生存和退热的有益影响。
Crit Care. 2019 Nov 20;23(1):363. doi: 10.1186/s13054-019-2632-1.
9
Bloodstream infection with extended-spectrum beta-lactamase-producing Escherichia coli: The role of virulence genes.产超广谱β-内酰胺酶大肠杆菌血流感染:毒力基因的作用。
J Microbiol Immunol Infect. 2019 Dec;52(6):947-955. doi: 10.1016/j.jmii.2019.03.005. Epub 2019 Mar 29.
10
Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.台湾一家医学中心社区获得性第三代头孢菌素耐药大肠埃希菌菌血症的流行率及危险因素。
BMC Infect Dis. 2019 Mar 12;19(1):245. doi: 10.1186/s12879-019-3880-z.